Weitere ähnliche Inhalte Ähnlich wie MCC 2011 - Slide 22 Ähnlich wie MCC 2011 - Slide 22 (20) Mehr von European School of Oncology Mehr von European School of Oncology (20) Kürzlich hochgeladen (20) 4. Results of hepatic resection for colorectal cancer Source: Uptodate Rationale to FU Approaches Trials Framing CEAwatch Summary Author and year Number of patients 5 yr OS, percent Hughes, KS; 1986 607 33 Scheele, J; 1995 434 33 Nordlinger, B; 1996 1568 28 Jamison, RL; 1997 280 27 Fong, Y; 1999 1001 37 Iwatsuki, S; 1999 305 32 Choti, M; 2002 133 58 Abdalla, E; 2004 190 58 Fernandez, FG; 2004 100 58 Wei, AC; 2006 423 47 Rees, M; 2008 929 36 De Jong, M; 2009 1669 47 Morris, EJ; 2010 3116 44 8. . Chau I et al. JCO 2004;22:1420-1429 ©2004 by American Society of Clinical Oncology Rationale Approaches to FU Trials Framing CEAwatch Summary 16. . Chau I et al. JCO 2004;22:1420-1429 ©2004 by American Society of Clinical Oncology Rationale Approaches to FU Trials Framing CEAwatch Summary 21. . Chau I et al. JCO 2004;22:1420-1429 ©2004 by American Society of Clinical Oncology Rationale Approaches to FU Trials Framing CEAwatch Summary 35. APR 02-07-2010 female pt 10-06-1960 T3N0 Rationale Approaches to FU Trials Framing CEAwatch Summary 38. Stepped wedge design Patients in control group Time Patients in intervention group 1st Hospital randomization Rationale Approaches to FU Trials Framing CEAwatch Summary
![This talk: ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)